Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Andrographolide sulfonate in acute exacerbation of chronic bronchitis
NCT03132610Phase 4Unknown
- Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Start
- Dec 2016
- Primary completion
- Dec 2017
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of andrographolide sulfonate in chronic bronchitis (CB), sponsored by Jiangxi Qingfeng Pharmaceutical Co. Ltd.. Status: unknown.
02
Drugs
andrographolide sulfonate
03
Conditions
chronic bronchitis (CB)
Beyond the preview
Go deeper on NCT03132610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03132610.